Logo-bi
Bioimpacts. 2013;3(1): 1-4.
doi: 10.5681/bi.2013.009
PMID: 23678463
PMCID: PMC3648910
Scopus ID: 84879192201
  Abstract View: 1433
  PDF Download: 817

Editorial

Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy

S. Moein Moghimi*, Fatemeh Rahbarizadeh, Davoud Ahmadvand, Ladan Parhamifar
*Corresponding Author: Email: moien.moghimi@sund.ku.dk

Abstract

Unlike conventional antibodies, heavy chain only antibodies derived from camel contain a single variable domain (VHH) and two constant domains (CH2 and CH3). Cloned and isolated VHHs possess unique properties that enable them to excel conventional therapeutic antibodies and their smaller antigen-binding fragments in cancer targeting and therapy. VHHs express low immunogenicity, are highly robust and easy to manufacture and have the ability to recognize hidden or uncommon epitopes. We highlight the utility of VHH in design of new molecular, multifunctional particulate and immune cell-based systems for combating HER2+ breast cancer.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 1434

Your browser does not support the canvas element.


PDF Download: 817

Your browser does not support the canvas element.

Submitted: 20 Jan 2013
ePublished: 27 Jan 2013
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)